AstraZeneca

AstraZeneca May Acquire Relypsa for $46/Share; Stock Surges
Bidness, ETC
Thu, 12/24/15 - 10:24 am
AstraZeneca
Relypsa
M&A
The year's top pharma marketing controversies
Medical Marketing and Media
Wed, 12/23/15 - 09:50 pm
FDA
drug pricing
Amarin
social media
PBMs
AstraZeneca
Pfizer
Valeant Pharmaceuticals
drug ads
Afrezza
AstraZeneca bags FDA OK on gout drug lesinurad as safety doubts linger
Fierce Biotech
Wed, 12/23/15 - 11:14 am
AstraZeneca
FDA
lesinurad
gout
The Right Drug For Big Pharma: Precision M&A
Seeking Alpha
Tue, 12/22/15 - 10:55 am
M&A
AstraZeneca
GSK
JNJ
Novartis
Sanofi
AstraZeneca's Acerta deal could put the hurt on AbbVie's Imbruvica
Fierce Pharma Marketing
Tue, 12/22/15 - 10:40 am
AstraZeneca
Acerta
AbbVie
M&A
Imbruvica
Boehringer grabs 'breakthrough,' plots pivotal trials for rival to AstraZeneca, Clovis
Fierce Biotech
Mon, 12/21/15 - 10:50 am
Boehringer Ingelheim
breakthrough therapies
BI1482694
AstraZeneca
Clovis Oncology
non-small cell lung cancer
Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie?
Bidness, ETC
Sun, 12/20/15 - 04:45 pm
Gilead Sciences
AstraZeneca
AbbVie
filgotinib
Acerta Pharma
Galapagos
AstraZeneca hit with setback as durvalumab falls further behind on lung cancer
Fierce Biotech
Sat, 12/19/15 - 11:28 am
AstraZeneca
durvalumab
PDL-1 inhibitors
lung cancer
Why AstraZeneca Acquired Majority Stake in Acerta?
Bidness, ETC
Thu, 12/17/15 - 09:44 am
AstraZeneca
Acerta Pharma
M&A
acalabrutinib
AstraZeneca, Gilead Drug License Deals Could Pinch AbbVie Growth
TheStreet.com
Thu, 12/17/15 - 09:40 am
AstraZeneca
Gilead Sciences
AbbVie
Acerta Pharma
Galapagos
AstraZeneca buys most of Acerta for $4 bln to add cancer drug
Yahoo/Reuters
Thu, 12/17/15 - 09:29 am
AstraZeneca
Acerta Pharma
M&A
acalabrutinib
AstraZeneca supercharging its Asia strategy with WuXi and Takeda deals
Fierce Pharma
Wed, 12/16/15 - 03:47 pm
AstraZeneca
Asia
WuXi
Takeda
R&D
China
AstraZeneca (AZN) Stock Down in Pre-Market Trading on Possible Acerta Pharma Acquisition
TheStreet.com
Mon, 12/14/15 - 10:58 am
Acerta Pharma
AstraZeneca
AstraZeneca’s Share Price Is Volatile, Depends on Lesinurad
Yahoo/Market Realist
Tue, 12/8/15 - 11:04 pm
AstraZeneca
lesinurad
[video]Top FDA Drug Approvals in 2015: Lung Cancer
Motley Fool
Tue, 12/8/15 - 10:41 pm
FDA
lung cancer
AstraZeneca
Tagrisso
AstraZeneca to use mobile app in cancer trials
Medical Marketing and Media
Tue, 12/8/15 - 10:11 am
AstraZeneca
mobile apps
clinical trials
Can AstraZeneca Live Up to Its $45 Billion Promise?
Motley Fool
Thu, 12/3/15 - 09:37 am
AstraZeneca
3 Leaders In Alzheimer's BACE Inhibition
Seeking Alpha
Wed, 12/2/15 - 11:05 am
Alzheimer's disease
Amgen
AstraZeneca
BACE inhibitors
Eli Lilly
Merck
Novartis
Robots, sound waves, and software: How AZ is beefing up tech at its UK R&D hub
BioPharma Dive
Wed, 11/25/15 - 10:54 am
AstraZeneca
R&D
AstraZeneca Sells Drug Rights To Perrigo
Bidness, ETC
Mon, 11/23/15 - 09:33 am
AstraZeneca
Perrigo Company
Entocort
Crohn's Disease

Pages